- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有6家主力机构披露2025-06-30报告期持股数据，持仓量总计2.55亿股，占流通A股63.80%
- 波段诊断：
-
技术面诊股
诊断结果：3.8技术面打败了8%的股票
技术面评分前10的股票
近期的平均成本为8.79元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.79元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.79","date":1760347643,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.10.14","stock":"0.00","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-1.35","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"0.79","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"-0.23","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"0.57","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"-0.90","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"1.03","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"-1.13","trade":"-0.70","ind":"-0.01"},{"date":"2025.09.24","stock":"0.57","trade":"1.12","ind":"0.83"},{"date":"2025.09.23","stock":"-2.54","trade":"-1.40","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.33","trade":"-0.53","ind":"0.22"},{"date":"2025.09.19","stock":"-0.77","trade":"-1.04","ind":"-0.30"},{"date":"2025.09.18","stock":"-0.97","trade":"-1.21","ind":"-1.15"},{"date":"2025.09.17","stock":"-0.43","trade":"-0.25","ind":"0.37"},{"date":"2025.09.16","stock":"1.20","trade":"0.68","ind":"0.04"},{"date":"2025.09.15","stock":"-0.76","trade":"-0.41","ind":"-0.26"},{"date":"2025.09.12","stock":"-0.22","trade":"-0.31","ind":"-0.12"},{"date":"2025.09.11","stock":"-0.75","trade":"0.43","ind":"1.65"},{"date":"2025.09.10","stock":"0.65","trade":"0.02","ind":"0.13"},{"date":"2025.09.09","stock":"-1.17","trade":"-1.27","ind":"-0.51"},{"date":"2025.09.08","stock":"1.63","trade":"1.30","ind":"0.38"}]
ST葫芦娃,上证指数,中药指数
压力支撑
该股压力位为8.75元，支撑位为8.67元。
[{"text":"\u538b\u529b\u4f4d","value":"8.75","date":1760371200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.67","date":1760371200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了15%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：10月15日 08:19
| 机构今日流向(万元) | -71.30 | 机构5日流向(万元) | -975.70 |
| 机构10日流向(万元) | -4666.21 | 机构20日流向(万元) | -21844.56 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加55.19万股，其中基金数没有增加，主力净减仓7家，暂未发现中长期投资价值。
截止2025-06-30，共6家主力机构（一般法人3家，QFII3家），持仓量总计25528.2万股，占流通A股63.80%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有315.7万股
从主力名单中消失：10家 ，原持有260.51万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有315.7万股
从主力名单中消失：10家 ，原持有260.51万股
消息面诊股
诊断结果：4.9消息面打败了3%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 【瞩目】葫芦娃再添新品，挺进消化用药千亿赛道
2025-10-09 - 行业追踪|中医药市场（9月29日-10月5日）：综
2025-10-05 - ST葫芦娃：公司在呼吸系统、消化系统及精神类等赛道
2025-09-30 - 行业追踪|中医药市场（9月22日-9月28日）：综
2025-10-02 - 吸入剂6大集采品种大跌！3个10亿大品种领跑，恒瑞
2025-09-25 - 行业追踪|中医药市场（9月15日-9月21日）：综
2025-10-02 - 葫芦娃再获突破!三款药品获国家药监局注册及临床批准
2025-09-18 - ST葫芦娃：获药物临床试验批准通知书
2025-09-15 - ST葫芦娃：公司及全资子公司获得药品注册证书
2025-09-15 - 行业追踪|中医药市场（9月8日-9月14日）：综合
2025-10-02
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-30 |
| 一般消息 | 募资投向 | 2025-09-18 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-08-26 |
| 一般消息 | 高管变动 | 退休 | 2025-07-20 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-15 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-06-24 |
| 利空 | 上市变动 | 特别处理ST | 2025-04-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-04-28 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-04-23 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-03-15 |
| 一般消息 | 高管变动 | 为更好地履行董事长职责，将更多精力... | 2025-03-04 |
| 一般消息 | 高管变动 | 因已连续担任公司独立董事满6年 | 2024-11-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-02 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 6条 | 1条 | 5条 |
行业面诊股
诊断结果：2.5行业面打败了35%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"},{"date":"2025.09.24","price":"0.83","value":"1.12"},{"date":"2025.09.23","price":"-0.18","value":"-1.40"},{"date":"2025.09.22","price":"0.22","value":"-0.53"},{"date":"2025.09.19","price":"-0.30","value":"-1.04"},{"date":"2025.09.18","price":"-1.15","value":"-1.21"},{"date":"2025.09.17","price":"0.37","value":"-0.25"},{"date":"2025.09.16","price":"0.04","value":"0.68"},{"date":"2025.09.15","price":"-0.26","value":"-0.41"},{"date":"2025.09.12","price":"-0.12","value":"-0.31"},{"date":"2025.09.11","price":"1.65","value":"0.43"},{"date":"2025.09.10","price":"0.13","value":"0.02"},{"date":"2025.09.09","price":"-0.51","value":"-1.27"},{"date":"2025.09.08","price":"0.38","value":"1.30"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 47.17% | 38.26% | 6.7分 |
| 2 | 吉林敖东 | 7.09% | 0.64% | 6.1分 |
| 3 | 方盛制药 | 6.20% | 0.17% | 6.5分 |
| 4 | 马应龙 | 3.87% | 6.94% | 6.5分 |
| 5 | 信邦制药 | 1.36% | 7.83% | 6.1分 |
| 6 | 江中药业 | 1.26% | 1.17% | 6.6分 |
| 8 | 太极集团 | 0.40% | 2.24% | 6.3分 |
| 10 | 嘉应制药 | -0.15% | 4.20% | 6.2分 |
| 12 | 天目药业 | -0.80% | 2.03% | 6.4分 |
| 14 | 桂林三金 | -1.26% | 2.26% | 7.0分 |
| 16 | 昆药集团 | -1.68% | 0.00% | 4.6分 |
| 18 | 康恩贝 | -2.00% | 1.14% | 6.5分 |
| 20 | 华润三九 | -2.16% | 2.91% | 6.9分 |
| 22 | ST香雪 | -2.35% | 1.60% | 3.9分 |
| 24 | 沃华医药 | -2.87% | 3.21% | 6.7分 |
| 26 | 上海凯宝 | -2.89% | -0.17% | 4.9分 |
| 28 | 天士力 | -2.98% | 2.11% | 6.6分 |
| 30 | 葵花药业 | -3.46% | -0.13% | 5.0分 |
| 32 | 陇神戎发 | -3.59% | 2.90% | 6.5分 |
| 34 | 仁和药业 | -4.03% | 1.81% | 5.5分 |
| 36 | 济川药业 | -4.06% | 0.97% | 5.4分 |
| 38 | 亚宝药业 | -4.40% | 3.53% | 6.4分 |
| 40 | 东阿阿胶 | -4.69% | -0.67% | 5.9分 |
| 42 | 红日药业 | -5.12% | 0.54% | 5.4分 |
| 44 | 贵州三力 | -5.73% | -2.53% | 4.9分 |
| 46 | 华神科技 | -5.96% | -1.04% | 5.3分 |
| 48 | 千金药业 | -6.03% | 1.16% | 6.2分 |
| 50 | 步长制药 | -6.35% | -1.98% | 5.2分 |
| 52 | 粤万年青 | -6.73% | 2.62% | 5.7分 |
| 54 | 以岭药业 | -6.81% | 0.00% | 5.3分 |
| 56 | 汉森制药 | -7.36% | 0.31% | 5.8分 |
| 58 | 达仁堂 | -7.99% | 0.14% | 5.3分 |
| 60 | 启迪药业 | -8.40% | -3.22% | 4.3分 |
| 62 | 康惠股份 | -10.11% | -3.54% | 4.3分 |
| 64 | 贵州百灵 | -10.72% | 0.19% | 4.4分 |
| 66 | 康缘药业 | -13.35% | 0.13% | 4.9分 |
| 68 | 恩威医药 | -14.66% | -5.45% | 5.6分 |
| 70 | 众生药业 | -20.46% | -2.42% | 5.0分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 57/110 ， 48/110。
[{"date":"2025-06-30","value":"0.34","vol":"3.94"},{"date":"2025-03-31","value":"3.42","vol":"2.20"},{"date":"2024-12-31","value":"-31.82","vol":"4.81"},{"date":"2024-09-30","value":"-12.49","vol":"2.92"},{"date":"2024-06-30","value":"4.03","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.34 | 3.42 | -31.82 | -12.49 | 4.03 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"43.28","vol":"52.43"},{"date":"2025-03-31","value":"39.21","vol":"52.92"},{"date":"2024-12-31","value":"47.85","vol":"52.40"},{"date":"2024-09-30","value":"50.06","vol":"52.75"},{"date":"2024-06-30","value":"51.34","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
43.28 | 39.21 | 47.85 | 50.06 | 51.34 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 65/110 ， 63/110。
[{"date":"2025-06-30","value":"-42.89","vol":"-6.98"},{"date":"2025-03-31","value":"-28.42","vol":"-6.63"},{"date":"2024-12-31","value":"-21.26","vol":"-6.97"},{"date":"2024-09-30","value":"-19.20","vol":"-4.57"},{"date":"2024-06-30","value":"-2.74","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-42.89 | -28.42 | -21.26 | -19.20 | -2.74 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-94.14","vol":"2.33"},{"date":"2025-03-31","value":"-11.23","vol":"-36.42"},{"date":"2024-12-31","value":"-2629.23","vol":"-142.71"},{"date":"2024-09-30","value":"-251.67","vol":"63.06"},{"date":"2024-06-30","value":"-33.04","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-94.14 | -11.23 | -2629.23 | -251.67 | -33.04 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 49/110 ， 50/110。
[{"date":"2025-06-30","value":"0.17","vol":"0.24"},{"date":"2025-03-31","value":"0.11","vol":"0.12"},{"date":"2024-12-31","value":"0.48","vol":"0.49"},{"date":"2024-09-30","value":"0.36","vol":"0.37"},{"date":"2024-06-30","value":"0.30","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.11 | 0.48 | 0.36 | 0.30 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.69","vol":"1.17"},{"date":"2025-03-31","value":"0.45","vol":"0.60"},{"date":"2024-12-31","value":"2.03","vol":"2.40"},{"date":"2024-09-30","value":"1.50","vol":"1.79"},{"date":"2024-06-30","value":"1.45","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.69 | 0.45 | 2.03 | 1.50 | 1.45 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/110 ， 50/110。
[{"date":"2025-06-30","value":"66.01","vol":"20.17"},{"date":"2025-03-31","value":"-29.28","vol":"0.38"},{"date":"2024-12-31","value":"14.64","vol":"15.45"},{"date":"2024-09-30","value":"-37.45","vol":"6.15"},{"date":"2024-06-30","value":"9.40","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 66.01 | -29.28 | 14.64 | -37.45 | 9.40 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.30","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.98","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"4.44","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.30 | - | 1.98 | - | 4.44 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 38/110 ， 28/110。
[{"date":"2025-06-30","value":"0.89","vol":"2.88"},{"date":"2025-03-31","value":"0.84","vol":"2.97"},{"date":"2024-12-31","value":"0.85","vol":"2.86"},{"date":"2024-09-30","value":"0.87","vol":"3.22"},{"date":"2024-06-30","value":"1.02","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.89 | 0.84 | 0.85 | 0.87 | 1.02 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.50","vol":"2.11"},{"date":"2025-03-31","value":"0.44","vol":"2.20"},{"date":"2024-12-31","value":"0.47","vol":"2.09"},{"date":"2024-09-30","value":"0.45","vol":"2.40"},{"date":"2024-06-30","value":"0.68","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.50 | 0.44 | 0.47 | 0.45 | 0.68 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 40/110 ， 3/110。
[{"date":"2025-06-30","value":"74.34","vol":"33.91"},{"date":"2025-03-31","value":"74.48","vol":"33.34"},{"date":"2024-12-31","value":"74.93","vol":"34.08"},{"date":"2024-09-30","value":"68.11","vol":"32.93"},{"date":"2024-06-30","value":"65.16","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
74.34 | 74.48 | 74.93 | 68.11 | 65.16 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.08","vol":"0.74"},{"date":"2025-03-31","value":"3.09","vol":"0.72"},{"date":"2024-12-31","value":"3.17","vol":"0.74"},{"date":"2024-09-30","value":"2.24","vol":"3.16"},{"date":"2024-06-30","value":"1.94","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
3.08 | 3.09 | 3.17 | 2.24 | 1.94 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.72","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.11","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.74","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]